IVIEW THERAPEUTICS

iview-therapeutics-logo

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis. The company was founded in 2015 by Bo Liang and John Baldwin and is based in Doylestown, Pennsylvania, United States.

#SimilarOrganizations #People #Financial #Website #More

IVIEW THERAPEUTICS

Industry:
Biotechnology Health Care Medical Medical Device Therapeutics

Founded:
2015-01-01

Address:
Doylestown, Pennsylvania, United States

Country:
United States

Website Url:
http://www.iviewtherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
267-370-5223

Total Funding:
55.03 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Wordpress Plugins Contact Form 7 COVID-19 ASP.NET IIS Sectigo SSL Sectigo Domain SSL


Similar Organizations

1e-therapeutics-logo

1E Therapeutics

1E Therapeutics is a breakthrough, drug development company.

advanced-chemotherapy-technologies-logo

Advanced Chemotherapy Technologies

Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

invivo-therapeutics-logo

InVivo Therapeutics

InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kinaset-therapeutics-logo

Kinaset Therapeutics

Kinaset Therapeutics is a therapeutics company that focuses on advancement of novel drugs in areas of unmet medical needs.

madeira-therapeutics-logo

Madeira Therapeutics

Madeira Therapeutics is a drug development company specializing in real pediatric medicine by reformulating compounds.

measurement-analytics-logo

Measurement Analytics

Measurement Analytics, Inc. (MAI) is an intellectual property company that has acquired technology utilization rights.

mirabilis-medical-logo

Mirabilis Medical

Mirabilis Medical is a medical device company that focuses on the treatment of uterine fibroids that is a common problem for women.

newsoara-logo

Newsoara

Newsoara is a biomedical technology developer that specializes in the development of medical devices.

noctrix-health-logo

Noctrix Health

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

pic-therapeutics-logo

PIC Therapeutics

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

salvia-bioelectronics-logo

Salvia BioElectronics

Salvia is an innovative start-up active in the emerging field of BioElectronics.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

syantra-logo

Syantra

Syantra is a precision healthcare company that focuses on the commercialization of breast cancer detection blood tests.

treace-medical-concepts-logo

Treace Medical Concepts

Treace Medical Concepts is a privately-funded development stage company that specializes in foot and ankle surgical products.

ulink-labs-logo

uLink Labs

uLink Labs is a medical device company that specializes in next-generation medical devices innovations.

Current Employees Featured

john-j-baldwin_image

John J. Baldwin
John J. Baldwin Co-Founder @ iVIEW Therapeutics
Co-Founder

not_available_image

Mark Palmer
Mark Palmer Chief Business Officer @ iVIEW Therapeutics
Chief Business Officer
2021-06-01

not_available_image

Hany Michail
Hany Michail Chief Medical Officer @ iVIEW Therapeutics
Chief Medical Officer

not_available_image

Bo Liang
Bo Liang Co-Founder, Director, Chairman and President @ iVIEW Therapeutics
Co-Founder, Director, Chairman and President
2015-08-01

Founder


not_available_image

Bo Liang

john-j-baldwin_image

John J. Baldwin

Investors List

prox-ventures_image

Prox Ventures

Prox Ventures investment in Seed Round - iVIEW Therapeutics

Official Site Inspections

http://www.iviewtherapeutics.com Semrush global rank: 8.69 M Semrush visits lastest month: 266

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "iVIEW Therapeutics"

iView Therapeutics |Becoming a Leader in Ophthalmic Therapeutics|

Jan 8, 2025 Becoming a Leader in Ophthalmic Therapeutics. Bright Science, Clear Vision. iVIEW Therapeutics Inc. is a clinical-stage ophthalmology-focused therapeutics company …See details»

Becoming a Leader in Ophthalmic Therapeutics

IVIEW Therapeutics Inc. is a clinical stage biotechnology company focusing on innovative ophthalmic therapeutics. We are driven by the pursuit of innovative science that leads to …See details»

iVIEW Therapeutics - Crunchbase Company Profile & Funding

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis. The company was founded in 2015 by Bo Liang and John …See details»

IVIEW Therapeutics Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for IVIEW Therapeutics Inc of Cranbury, NJ. Get the latest business insights from Dun & Bradstreet.See details»

IView Therapeutics - LinkedIn

IVIEW Therapeutics Inc. is a clinical stage ophthalmology drug development company. Our novel drug development strategies are centered in: - Novel extended-release formulations - …See details»

Becoming a Leader in Ophthalmic Therapeutics

Dry Eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, …See details»

IVIEW Therapeutics Completed A++ Round Financing

Jan 17, 2025 For additional information, please visit our website at www.iviewtherapeutics.com. For further inquiries or media contacts, please reach out to our team at info@iviewinc.com. …See details»

iView Therapeutics - PitchBook

IView Therapeutics General Information Description. Developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. The company develops drugs including long-acting povidone-iodine ophthalmic …See details»

IVIEW Therapeutics Inc | VentureRadar

Website: http://iviewtherapeutics.com/ Develops innovative ophthalmic therapies addressing unmet medical needs in dry eye, myopia, viral conjunctivitis, and glaucoma ...See details»

IVIEW Therapeutics, Inc. - Business Profile - iviewtherapeutics

View IVIEW Therapeutics, Inc.'s business profile on PRLog, with profiles from 390,000 organizations. iVIEW Therapeutics Inc. is a clinical stage biotechnology company focusing on …See details»

IVIEW Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Www.iviewtherapeutics.com. Startups | Holding Company | 2015 | Pennsylvania, United States | < 10 | www.iviewtherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ... The …See details»

IVIEW Therapeutics - Overview, News & Similar companies

Feb 28, 2024 Who is IVIEW Therapeutics. iVIEW Therapeutics Inc. is a clinical stage ophthalmology drug development company. Its lead compound iVIEW-1201 is starting global …See details»

Becoming a Leader in Ophthalmic Therapeutics

[Cranbury, NJ, March 11, 2024] iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. …See details»

IVIEW Therapeutics Announces the Completion of ... - Alpha …

Oct 4, 2021 IVIEW is headquartered at 5 Cedar Brook Drive, Cranbury, NJ (the greater-Princeton area). IVIEW was founded by experienced pharmaceutical veterans and clinical …See details»

IVIEW Therapeutics Inc - VentureRadar

Similar Companies: Sun BioPharma USA Private Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and MGI …See details»

Becoming a Leader in Ophthalmic Therapeutics

I-Gel In-situ Gel Technology. The i-GEL sustained release technology is a novel in-situ gel delivery platform, which presents unique properties of sol-to-gel phase transition on …See details»

IVIEW Therapeutics Inc Overview - Salary.com

Discover essential details about IVIEW Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»

IVIEW Therapeutics Announces Topline Results from Phase 1/2 …

1 day ago CRANBURY, N.J., Feb. 10, 2025 /PRNewswire/ -- IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular …See details»

IVIEW Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore IVIEW Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, and 2 literature, Disease Domain:Infectious ...See details»

IVIEW Therapeutics Inc - VentureRadar

Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»

linkstock.net © 2022. All rights reserved